| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | Nov 24, 2025 | Inhibikase Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +2,068,965 | 18.89% | ✗ | $3M |
| Jul 6, 2021 | Jul 8, 2021 | Acumen Pharmaceuticals, Inc. | 10% Owner | Buy | 100.0 | +450,000 | 15.17% | ✗ | $6.7M |